Luzanne Otte: Why Advocacy and Funding Still Matter in Fighting Glioblastoma

Glioblastoma treatment advocacy and funding

photo credit: Anna Shvets / Pexels

Key Takeaways

  • Glioblastoma is the most common malignant brain tumor in adults and remains one of the most difficult cancers to treat effectively.
  • Advocacy organizations help accelerate research, connect patients with resources, and increase participation in clinical trials.
  • Emerging research areas include immunotherapy, gene-based treatments, and personalized medicine approaches.
  • Consistent research funding is critical because even unsuccessful clinical trials often provide valuable data for future breakthroughs.
  • Public awareness and community involvement can help drive funding, influence policy decisions, and strengthen support networks for patients and caregivers.
Continue reading